[1] Li H, Yang L, Zheng CY, et al. Use of bronchoalveolar lavage enzyme-linked immunospot for diagnosis of smear-negative pulmonary tuberculosis. Int J Tuberc Lung Dis, 2012; 16, 1668-73. doi:  10.5588/ijtld.12.0292
[2] Saravanan M, Niguse S, Abdulkader M, et al. Review on emergence of drug-resistant tuberculosis (MDR & XDR-TB) and its molecular diagnosis in Ethiopia. Microb Pathog, 2018; 117, 237-42. doi:  10.1016/j.micpath.2018.02.047
[3] Saravanan M, Duche K, Asmelash T, et al. "Nano-Biomaterials"-A New Approach Concerning Multi-Drug Resistant Tuberculosis (MDR-TB). Pharmaceutical Nanotechnology, 2015; 3, 5-18. doi:  10.2174/2211738503666150415230743
[4] Lin L, Tan B, Pantapalangkoor P, et al. Inhibitionof LpxC protects mice from resistant Acinetobacter baumannii by modulatinginflammation and enhancing phagocytosis. MBio, 2012; 3, pii:e00312-12. http://europepmc.org/abstract/MED/23033474
[5] Alavi SM. Comparative evaluation of three and six month therapeutic regimens for smear negative pulmonary tuberculosis. Jundishapur Journal of Microbiology, 2009; 2, 153-8. http://d.old.wanfangdata.com.cn/OAPaper/oai_doaj-articles_ada4fc9ac2ca2f771c4af5f96ecad2e4
[6] Yakhelef N, Audibert M, Varaine F, et al. Is introducing rapid culture into the diagnostic algorithm of smear-negative tuberculosis cost-effective? Int J Tuberc Lung Dis, 2014; 18, 541-6. doi:  10.5588/ijtld.13.0630
[7] Merle CS, Fielding K, Sow OB, et al. A four-month gatifloxacin-containing regimen for treating tuberculosis. N Engl J Med, 2014; 371, 1588-98. doi:  10.1056/NEJMoa1315817
[8] World Health Organization (WHO). Cost-effectiveness thresholds. Cost effectiveness and strategic planning (WHOCHOICE). http://www.who.int/choice/cost-effectiveness/methods/en/[2018-04-09].
[9] Zhang F, Liu C. The clinical analysis on 412 primary smear and culture negative pulmonary tuberculosis cases. Journal of the Chinese Antituberculosis Association, 2007; 4, 309-11. (In Chinese) http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgflzz200704005
[10] Viney K, Bissell K, Tabutoa K, et al. Sputum smear examination and time to diagnosis in patients with smear-negative pulmonary tuberculosis in the Pacific. Public Health Action, 2011; 2, 133-7. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4463071/